Cardiology Guidelines
Quick-reference summaries of major society guidelines — ACC/AHA, ESC, and HRS. Each guideline will include a 1-page summary, decision algorithms, key tables, and related calculators.
Prevention & Risk Assessment
Guidelines for cardiovascular risk assessment, lipid management, hypertension, obesity, and diabetes in CV disease.
Cholesterol Clinical Practice Guidelines
Management of blood cholesterol — statin therapy, risk-enhancers, CAC scoring, and treatment thresholds.
2018 (2023 update) View guideline ACC/AHAHypertension Guidelines
Prevention, detection, evaluation, and management of high blood pressure in adults.
2017 View guideline ESCCVD Prevention in Clinical Practice
European guidelines on cardiovascular disease prevention including SCORE2 risk assessment.
2021 View guideline AHAPREVENT Equations
2024 AHA PREVENT equations — 10- and 30-year total CVD risk incorporating eGFR, HbA1c, and UACR.
2024 View guideline ACC/AHAChronic Coronary Disease
Management of chronic coronary disease — anti-ischemic therapy, revascularization, and secondary prevention.
2023 View guidelineHeart Failure
Guidelines for the diagnosis, staging, and management of heart failure — HFrEF, HFpEF, advanced HF, and mechanical circulatory support.
Heart Failure Management
Comprehensive guidelines for HF diagnosis and management — GDMT, device therapy, and advanced HF pathways.
2022 View guideline ESCHeart Failure Diagnosis & Treatment
ESC guidelines for acute and chronic heart failure — treatment algorithms, device indications, and comorbidity management.
2021 (2023 update) View guideline ACC Expert ConsensusSGLT2 Inhibitors in Heart Failure
Expert consensus decision pathway for SGLT2i use across the HF spectrum.
2024 View guidelineArrhythmias & Electrophysiology
Guidelines for atrial fibrillation, ventricular arrhythmias, SVT, bradycardia, sudden cardiac death, and device therapy.
Atrial Fibrillation Management
Comprehensive AF guidelines — classification, stroke prevention, rate vs. rhythm, catheter ablation, and surgical approaches.
2024 View guideline ESCAtrial Fibrillation
ESC guidelines for AF diagnosis and management — AF-CARE pathway, anticoagulation, and rhythm control strategies.
2024 View guideline AHA/ACC/HRSVentricular Arrhythmias & SCD Prevention
Management of patients with ventricular arrhythmias and prevention of sudden cardiac death.
2017 View guideline ESCVentricular Arrhythmias & SCD
ESC guidelines for VA management and sudden cardiac death prevention — risk stratification and device therapy.
2022 View guideline ACC/AHA/HRSSupraventricular Tachycardia
Management of SVT — AVNRT, AVRT, atrial tachycardia, and accessory pathway-mediated tachycardias.
2015 View guideline ACC/AHA/HRSBradycardia & Conduction Delay
Evaluation and management of bradycardia and cardiac conduction delay — pacemaker indications and conduction system pacing.
2018 View guideline ESCCardiac Pacing & CRT
ESC guidelines on cardiac pacing and cardiac resynchronization therapy — including conduction system pacing.
2021 View guidelineInterventional Cardiology
Guidelines for ACS management, coronary revascularization, DAPT, and periprocedural antithrombotic therapy.
Coronary Artery Revascularization
Indications for PCI and CABG — stable ischemic heart disease and ACS decision pathways.
2021 View guideline ESCAcute Coronary Syndromes (NSTE-ACS)
ESC guidelines for non-ST-elevation ACS — risk stratification, invasive strategy timing, and antithrombotic therapy.
2023 View guideline ACC/AHADuration of DAPT in CAD
Focused update on duration of dual antiplatelet therapy — DAPT score, high bleeding risk, and de-escalation strategies.
2016 View guidelineStructural Heart Disease
Guidelines for valvular heart disease — aortic stenosis, mitral regurgitation, tricuspid disease, endocarditis, and transcatheter interventions.
Valvular Heart Disease
Comprehensive VHD guidelines — aortic stenosis, mitral and tricuspid disease, prosthetic valves, and endocarditis.
2020 View guideline ESC/EACTSValvular Heart Disease
ESC guidelines for management of valvular heart disease — including TAVI, MitraClip, and endocarditis prophylaxis.
2021 View guideline ESCInfective Endocarditis
ESC guidelines for prevention, diagnosis, and treatment of infective endocarditis.
2023 View guidelineCardiac Imaging
Appropriate use criteria and guidelines for echocardiography, cardiac CT, cardiac MRI, and nuclear cardiology.
Multimodality Imaging in Stable Ischemic Heart Disease
Appropriate use criteria for coronary revascularization imaging — stress testing, CTA, and nuclear imaging.
2019 View guideline ASE/EACVIEchocardiographic Assessment of Valve Stenosis
Recommendations for echocardiographic evaluation of native valvular stenosis — grading severity and pitfalls.
2017 View guideline SCMRCardiac MRI Clinical Indications
Society for Cardiovascular Magnetic Resonance — standardized protocols and clinical indications for CMR.
2022 View guidelineVascular Disease
Guidelines for peripheral arterial disease, aortic disease, venous thromboembolism, and pulmonary embolism.
Lower Extremity PAD
Management of patients with lower extremity peripheral artery disease — screening, medical therapy, and revascularization.
2016 View guideline ACC/AHAAortic Disease
Diagnosis and management of aortic disease — aortic aneurysm, dissection, and intramural hematoma.
2022 View guideline ESCPulmonary Embolism
ESC guidelines for diagnosis and management of acute pulmonary embolism — risk stratification and anticoagulation.
2019 View guidelinePulmonary Hypertension
Guidelines for diagnosis and classification of pulmonary hypertension — PAH-specific therapies, Group 2 PH, and CTEPH.
Pulmonary Hypertension
Diagnosis and treatment of pulmonary hypertension — updated hemodynamic definitions, risk assessment, and treatment algorithms.
2022 View guideline CHESTPAH Pharmacotherapy
CHEST guideline on pharmacotherapy for pulmonary arterial hypertension — treatment initiation and combination therapy.
2019 View guidelineCardio-Oncology
Guidelines for cardiovascular care in cancer patients — cardiotoxicity prevention, monitoring during chemotherapy, and survivorship.
Cardio-Oncology Guidelines
First comprehensive cardio-oncology guidelines — cardiovascular toxicity from cancer therapy, risk stratification, and surveillance protocols.
2022 View guideline ACC Expert ConsensusCV Complications of Cancer Therapy
Expert consensus for monitoring and management of cardiovascular complications in cancer patients.
2023 View guidelineSpecial Populations
Guidelines addressing cardiovascular care in pregnancy, athletes, adults with congenital heart disease, and the elderly.
Cardiovascular Disease in Pregnancy
Management of cardiovascular diseases during pregnancy — anticoagulation, valvular disease, cardiomyopathy, and arrhythmias.
2018 View guideline ESCSports Cardiology & Exercise in CV Disease
ESC guidelines on sports cardiology — pre-participation screening, exercise in patients with cardiovascular disease.
2020 View guideline AHA/ACCAdults with Congenital Heart Disease
Management of adults with congenital heart disease — surveillance, pregnancy considerations, and interventional timing.
2018 View guideline